Extracellular Zn2+-Dependent Amyloid-β1-42 Neurotoxicity in Alzheimer's Disease Pathogenesis
Extracellular Zn2+-Dependent Amyloid-β1-42 Neurotoxicity in Alzheimer's Disease Pathogenesis
复制标题
阿尔茨海默病发病机制中细胞外 Zn2+ 依赖性淀粉样蛋白-β1-42 的神经毒性
DOI:
10.1007/s12011-020-02131-w
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
Takeda A
中科院分区:
文献类型:
--
作者:
Sato Y;Takiguchi M;Tamano H;Takeda A
The basal level of extracellular Zn2+is in the range of low nanomolar (~ 10 nM) in the hippocampus. However, extracellular Zn2+dynamics plays a key role for not only cognitive activity but also cognitive decline. Extracellular Zn2+dynamics is modified by glutamatergic synapse excitation and the presence of amyloid-β1–42(Aβ1–42), a causative peptide in Alzheimer’s disease (AD). When human Aβ1–42reaches high picomolar (> 100 pM) in the extracellular compartment of the rat dentate gyrus, Zn-Aβ1–42complexes are readily formed and taken up into dentate granule cells, followed by Aβ1–42-induced cognitive decline that is linked with Zn2+released from intracellular Zn-Aβ1–42complexes. Aβ1–42-induced intracellular Zn2+toxicity is accelerated with aging because of age-related increase in extracellular Zn2+. The recent findings suggest that Aβ1–42secreted continuously from neuron terminals causes age-related cognitive decline and neurodegeneration via intracellular Zn2+dysregulation. On the other hand, metallothioneins (MTs), zinc-binding proteins, quickly serve for intracellular Zn2+-buffering under acute intracellular Zn2+dysregulation. On the basis of the idea that the defense strategy against Aβ1–42-induced pathogenesis leads to preventing the AD development, this review deals with extracellular Zn2+-dependent Aβ1–42neurotoxicity, which is accelerated with aging.